Yim AP - Search Results

1

Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.

Chan AT, Teo PM, Lam KC, Chan WY, Chow JH, Yim AP, Mok TS, Kwan WH, Leung TW, Johnson PJ. Chan AT, et al. Among authors: yim ap. Cancer. 1998 Sep 1;83(5):925-9. doi: 10.1002/(sici)1097-0142(19980901)83:5<925::aid-cncr18>3.0.co;2-x. Cancer. 1998. PMID: 9731896 Clinical Trial.

2

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.

Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P. Mok TS, et al. Cancer. 2002 Oct 1;95(7):1511-9. doi: 10.1002/cncr.10836. Cancer. 2002. PMID: 12237920 Free article. Clinical Trial.

3

Sequential chemotherapy with combination irinotecan and cisplatin followed by docetaxel for treatment-naïve patients with advanced non-small cell lung cancer.

Mok TS, Ho S, Chan G, Ho WM, Wong H, Chan AT, Yeo W, Yim AP, Chak K, Lee Y, Lam KC. Mok TS, et al. Among authors: yim ap. J Thorac Oncol. 2007 Sep;2(9):838-44. doi: 10.1097/JTO.0b013e3181461976. J Thorac Oncol. 2007. PMID: 17805062 Free article. Clinical Trial.

4

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.

Mok TS, Zee B, Chan AT, Yeo W, Yang WT, Yim A, Leung SF, Nguyen B, Leung TW, Johnson P. Mok TS, et al. Cancer. 2000 Aug 1;89(3):543-50. Cancer. 2000. PMID: 10931453 Clinical Trial.

5

Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.

Sy SM, Wong N, Lee TW, Tse G, Mok TS, Fan B, Pang E, Johnson PJ, Yim A. Sy SM, et al. Eur J Cancer. 2004 May;40(7):1082-94. doi: 10.1016/j.ejca.2004.01.012. Eur J Cancer. 2004. PMID: 15093586

6

Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.

Chan AT, Ho S, Yim AP, Chang AR, Cheng P, Yuen J, Leung TW, Johnson PJ. Chan AT, et al. Among authors: yim ap. Acta Oncol. 1996;35(2):221-7. doi: 10.3109/02841869609098505. Acta Oncol. 1996. PMID: 8639319 Review.

7

Lack of expression for the suppressor PML in human small cell lung carcinoma.

Zhang P, Chin W, Chow LT, Chan AS, Yim AP, Leung SF, Mok TS, Chang KS, Johnson PJ, Chan JY. Zhang P, et al. Among authors: yim ap. Int J Cancer. 2000 Mar 1;85(5):599-605. doi: 10.1002/(sici)1097-0215(20000301)85:5<599::aid-ijc1>3.0.co;2-#. Int J Cancer. 2000. PMID: 10699936

8

Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.

Sy SM, Wong N, Mok TS, Tsao MS, Lee TW, Tse G, Blackhall FH, Johnson PJ, Yim AP. Sy SM, et al. Among authors: yim ap. Lung Cancer. 2003 Jul;41(1):91-9. doi: 10.1016/s0169-5002(03)00138-7. Lung Cancer. 2003. PMID: 12826317

9

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.

Lee TW, Chen GG, Xu H, Yip JH, Chak EC, Mok TS, Yim AP. Lee TW, et al. Among authors: yim ap. Eur J Cancer. 2003 Jun;39(9):1296-301. doi: 10.1016/s0959-8049(02)00733-5. Eur J Cancer. 2003. PMID: 12763220

10

Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma.

Chen GG, Lee TW, Yip JH, Xu H, Lee IK, Mok TS, Warner TD, Yim AP. Chen GG, et al. Among authors: yim ap. Cancer Lett. 2006 Mar 28;234(2):193-8. doi: 10.1016/j.canlet.2005.03.032. Cancer Lett. 2006. PMID: 15876485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters